Cargando…

Response to second line antiretroviral therapy in India

Detalles Bibliográficos
Autores principales:	Singh, Anup, Chakravarty, Jaya, Gupta, Anoop, Sundar, Shyam, Rai, Madhukar, Singh, Avinash, Agarwal, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344784/ http://dx.doi.org/10.1186/1471-2334-12-S1-P40

Ejemplares similares

Optimal timing for initiation of antiretroviral therapy: a prospective study on treatment naive HIV patients
por: Chakravarty, Jaya, et al.
Publicado: (2012)

Outcome of patients on second line antiretroviral therapy under programmatic condition in India
por: Chakravarty, Jaya, et al.
Publicado: (2015)

Factors affecting default among pre-ART patients in Eastern Uttar Pradesh
por: Kansal, Sangeeta, et al.
Publicado: (2012)

Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2015)

Metabolic changes in the patients on second-line highly active antiretroviral therapy (HAART): A prospective cohort study from north India
por: Meena, Durga S., et al.
Publicado: (2020)

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2014)

Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India
por: Gautam, Abhilasha, et al.
Publicado: (2018)

Study the drug adherence and possible factor influencing drug adherence in HIV/AIDS patients in north eastern part of India
por: Meena, Lalit Prashant, et al.
Publicado: (2014)

Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
por: Singh, Om Prakash, et al.
Publicado: (2016)

Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral Leishmaniasis
por: Kumar, Dinesh, et al.
Publicado: (2013)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India
por: Singh, Abhishek Kumar, et al.
Publicado: (2023)

Emergence of HIV-1 drug resistance in antiretroviral therapy experienced perinatally infected children in South India
por: Neogi, Ujjwal, et al.
Publicado: (2012)

Peripheral arterial disease in antiretroviral therapy naïve HIV infected patients – an experience from eastern India
por: Khanra, Dibbendhu, et al.
Publicado: (2014)

Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
por: Sudarshan, Medhavi, et al.
Publicado: (2014)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
por: Khan, Samsuddin, et al.
Publicado: (2014)

Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India
por: Chakravarty, Jaya, et al.
Publicado: (2016)

Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
por: Gupte, Akshay N., et al.
Publicado: (2019)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India
por: Fakiola, Michaela, et al.
Publicado: (2019)

Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: A prospective study
por: Chakravarty, Jaya, et al.
Publicado: (2014)

Immunological response after initiation of second line anti-retroviral therapy in HIV patients
por: Achappa, Basavaprabhu, et al.
Publicado: (2012)

Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
por: Broder, MS, et al.
Publicado: (2010)

Proportion and determinants of adherence to antiretroviral therapy among HIV positive people registered under ART centre in South India
por: Hiregoudar, V, et al.
Publicado: (2014)

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
por: Bîstrițchi, Ina, et al.
Publicado: (2013)

Moringa oleifera supplementation by patients on antiretroviral therapy
por: Monera, TG, et al.
Publicado: (2010)

Initiating the antiretroviral therapy in treatment-naïve patients
por: Benea, Elisabeta, et al.
Publicado: (2014)

HIV prevalence among TB patients attending DOTS centres in rural Haryana, India
por: Balu, Ravi Kumar, et al.
Publicado: (2010)

Antimony Toxicity
por: Sundar, Shyam, et al.
Publicado: (2010)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Drug Resistance in Leishmaniasis
por: Chakravarty, Jaya, et al.
Publicado: (2010)

Treatment outcomes in patients receiving combination antiretroviral therapy
por: Agu, Kenneth, et al.
Publicado: (2010)

Outcome of first line antiretroviral therapy (art) with respect to treatment Failure at ART CENTRE, B. J. Medical College, Civil Hospital, Ahmedabad
por: Amin, Bipin, et al.
Publicado: (2010)

Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia
por: Bloch, M, et al.
Publicado: (2010)

Why do Patients in Pre-Anti Retroviral Therapy (ART) Care Default: A Cross-Sectional Study
por: Chakravarty, Jaya, et al.
Publicado: (2016)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

High diagnostic yield of line probe assay as a point-of care test in a TB rural setting
por: Kotwal, Aarti, et al.
Publicado: (2014)

Cross-clade neutralization potential of the plasma of antiretroviral naïve HIV-1 infected children from north India
por: Sankaran, Prakash Somi, et al.
Publicado: (2012)

Immune impairment and adaptive response in relation to antiretroviral therapy of HIV-infection
por: Kaminskiy, GD, et al.
Publicado: (2010)

Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
por: Palacios, R, et al.
Publicado: (2010)

The use of medical early warning scores in high-risk acute coronary syndrome patients in a district hospital setting
por: Turley, A, et al.
Publicado: (2006)

Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
por: Henrivaux, Philippe, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7ar22nrgqhp4m3u0fgl22nk8je